Notification letter to registered shareholders and reply form
Filed with HKEX · Stock code 2552 · · 2 pages · English and Chinese
Summary by 6ix AI
It informs shareholders that both English and Chinese versions of the report are available online and provides instructions for those who prefer printed copies. The letter emphasizes the importance of providing a functional email address for future communications. Additionally, it includes a personal information collection statement outlining how personal data will be handled.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Hua Medicine
- Interim report 2026
- Hua Medicine Announces 2026 Interim Results
- Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China
- Hua Medicine Announces 2025 Interim Results
- Hua Medicine Announces 2024 Annual Results
Later from Hua Medicine
- Notification letter to non-registered shareholders and request form
- Monthly Return of Equity Issuer on Movements in Securities
Follow Hua Medicine into a list and get an email when it puts out news.
Follow Hua Medicine